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Background: The WOMAC is the most widely used self-report measure to evaluate physical functioning in hip or
knee osteoarthritis, however its ability to discriminate pain and physical functioning (i.e. discriminate validity) has
repeatedly been questioned. Little to no data is available on the discriminant validity of alternative questionnaires
that measure the same construct, for instance the Hip and Knee Osteoarthritis Outcome Score (HOOS and KOOS,
respectively) and the Lower Extremity Function Scale (LEFS). Therefore, we translated the LEFS to Dutch and studied
its psychometric properties (i.e. validity, reliability and responsiveness). In addition, we assessed the discriminate
validity of the LEFS, HOOS and KOOS.
Methods: After translation with a forward/backward protocol, 401 individuals with hip or knee osteoarthritis
completed the LEFS, HOOS/KOOS, SF-36, Hospital Anxiety and Depression Scale and Checklist Individual Strength
questionnaires. To assess reliability and responsiveness, a sample of 106 and 108 patients completed a comparable
set of questionnaires within 3 weeks and 3 months, respectively. Feasibility, validity, reliability and responsiveness
were evaluated. Discriminant validity of the LEFS, HOOS and KOOS was examined by contrasting the scales’
correlations with the physical functioning subscale of the SF-36 with the scales’ correlations with the bodily pain
subscale of the SF-36.
Results: The Dutch version of the LEFS was feasible, had good internal consistency (0.96), good reliability
(ICC = 0.86), good construct and discriminant validity, and showed no floor or ceiling effects. The minimal
detectable change (MDC90) was ten points. Area under the receiver operating characteristic curve (AUC) analyses
revealed good (AUC= 0.76) and fair (AUC= 0.63) responsiveness for the LEFS in improved and worsened patients,
respectively. Discriminant validity for pain was apparent for the LEFS (p< 0.01), but not for the HOOS and KOOS
(p= 0.21 and p= 0.20, respectively).
Conclusions: Considering the LEFS’ good psychometric qualities and ability to discriminate between pain and
functioning, we recommend the LEFS as the outcome measure of choice to assess self-reported physical
functioning in individuals with hip or knee osteoarthritis.* Correspondence: t.hoogeboom@maartenskliniek.nl
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Numerous self-report measures on physical function are
available for the evaluation of patients with hip or knee
osteoarthritis [1]. Among those, the licensed for use
Western Ontario and McMaster University Osteoarth-
ritis Index (WOMAC) [2] is the most widely used [3]. It
is recommended by the Osteoarthritis Research Society
for use in clinical trials in patients with hip or knee
osteoarthritis to measure pain and disability [4]. How-
ever, consensus statements consistently advocate that
pain and physical function must be measured independ-
ently [3,5]. A solid body of evidence demonstrates that
the WOMAC-PF (Physical Function subscale) is unable
to discriminate between pain and function [6-9].
Recently, three new license free self-report measures
to determine functioning in patients with osteoarthritis
have become available; the Hip Osteoarthritis Outcome
Score (HOOS) [10], the Knee Osteoarthritis Outcome
Score (KOOS) [11] and the Lower Extremity Function
Scale (LEFS) [12]. One of those new measures, the LEFS,
showed promise as a competitive alternative to the
WOMAC-PF, as the LEFS can differentiate pain and
functioning [13] and detect changes in functional status
in the period immediately following surgery [14]. More-
over, the LEFS has excellent test-retest reliability, in-
ternal consistency and construct validity [12,13,15]. To
date, it remains to be seen, whether the physical func-
tion scales of the HOOS and KOOS can discriminate be-
tween pain and physical function [10,11,16].
Since the LEFS is currently not available in Dutch, the
primary purpose of this study was to evaluate the psycho-
metric qualities of the Dutch LEFS in people with hip or
knee osteoarthritis. Our secondary objective was to assess
the discriminant validity for pain of the physical function
subscale of the HOOS and KOOS and the LEFS.
Methods
First the English version of the LEFS was translated into
Dutch according to a standardized procedure described
by Beaton et al. [17], and secondly it was tested for psy-
chometric quality by use of prospective data.
Procedure of translation
The translation procedure consisted of four steps. First,
two persons translated independently of each other the
English version of the LEFS into Dutch (forward transla-
tion) (T1 & T2); one translator (TJH) had a medical back-
ground and was familiar with the concepts of the
questionnaire and the other (VvS) was a certified transla-
tor without a medical background. Both were native
speakers. Based on a consensus meeting one final version
(T-12) was formed. Second, two bilingual persons (T3 &
T4) translated the T-12 questionnaire back into English
(BT1 & BT2), to guarantee a consistent translation of thequestionnaire. Both translators (PA & DKJ) were unfamil-
iar with the original questionnaire, the concepts of the
questionnaire, and had no medical background. DKJ is
also a certified translator. Third, an expert meeting was
organised in which all translators, two health professionals
(CKS, ML), a methodologist (CHMvE) and two language
experts participated. During this meeting all versions of
questionnaires (T1, T2, T-12, BT1, BT2) were combined
and consensus on semantic, idiomatic, experiential and
conceptual equivalence was reached resulting in a pre-
final version of the questionnaire. The developers of the
original questionnaire approved all previous steps and the
final version. Finally, the pre-final version was presented
in a group of 33 patients (20 women and 13 men; age
(SD): 63 (13) years) to explore the clarity of the question-
naire. All patients were asked whether they understood
the items and whether they could interpret the question-
naires correctly. Also, the time needed to complete the
questionnaire was timed. The findings were discussed
among the translators, resulting in only minor changes to
the final Dutch version of the LEFS. Mean completion
time was 3.5 (SD=1.5) minutes. For the final version of
the Dutch LEFS see Appendix 1.Patients and procedure
Individuals (≥18 years) diagnosed with hip or knee osteo-
arthritis (inclusion period June till October 2009) by an
orthopaedic surgeon in the Sint Maartenskliniek hospital
Nijmegen were eligible. People reporting concurrent
rheumatoid arthritis, fibromyalgia or psoriatic arthritis,
were excluded. Written materials were sent by mail: this
included an information letter, an informed consent form,
the questionnaires and a return envelope. At baseline, all
patients completed four questionnaires, the LEFS, the
HOOS or KOOS (depending on index joint), the SF-36
and the Hospital Anxiety and Depression Scale (HADS).
A reminder was sent to those patients who did not re-
spond within three weeks, to ensure a high response rate.
One-hundred and twenty participants were sent a follow-
up questionnaire to evaluate test-retest reliability (within
3 weeks) and another 120 participants were sent a follow-
up questionnaire to evaluate responsiveness (after
3 months); as 100 participants were deemed sufficient
[13]. By use of random numbers the 240 patients were
selected to either the reliability or responsiveness study.
Both follow-up mailings consisted of three questionnaires
(LEFS, HOOS or KOOS, and the SF-36) and a global per-
ceived effect question. For test-retest reliability, we consid-
ered a time interval of 3 weeks to be appropriate for the
current population. For responsiveness, we deemed a
period up to 3 months long enough to allow for improve-
ment and brief enough to minimize the risk of a response
shift [18,19].
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Measures
The LEFS is a 20-item condition-specific questionnaire
designed to be applicable to individuals with musculo-
skeletal conditions of the lower extremity [12]. Each
item of the LEFS scores on a 5-point scale ranging from
0 to 4 points. When scoring the LEFS, up to 4 missing
item responses are permitted, for more detailed informa-
tion see Stratford et al. (2005) [20]. Accordingly, LEFS
scores range from 0 to 80 points, with higher scores
representing higher levels of functioning.
The HOOS and the KOOS include five subscales: Pain,
other Symptoms, Function in Daily living (ADL), Func-
tion in Sport and Recreation (Sport/Rec), and hip/knee-
related quality of life (QoL). Standardized response
options are given (5-point Likert scale) and each ques-
tion is scored from 0 to 4 points. Subsequently, a nor-
malized score (100 indicating no symptoms and 0
indicating extreme symptoms) is calculated for each sub-
scale. The Dutch HOOS and KOOS have good internal
consistency, construct validity, no floor and ceiling
effects and have been found to be reliable [10,11]. Both
the HOOS and KOOS questionnaires include the
WOMAC osteoarthritis-index in its complete and ori-
ginal format (with permission, www.koos.nu).
The SF-36 is a generic health status questionnaire
which contains 36 items [21]. It measures eight major
attributes (bodily pain; physical function; social function;
role limitations because of physical problems; role lim-
itations because of emotional problems; mental health;
vitality; general health perceptions). It is widely used, re-
liable, validated into Dutch and is easy to complete.
Higher scores indicate better health [22].
The Hospital Anxiety and Depression Scale (HADS) is
a 14-item scale designed to detect anxiety and depres-
sion, independent of somatic symptoms [23]. It consists
of two 7-item subscales measuring depression and anx-
iety on a 4-point response scale (from 0, no symptoms,
to 3, maximum symptoms), with possible scores for each
subscale ranging from 0 to 21. HADS is a valid and reli-
able screening instrument for detecting mood disorder
in people with osteoarthritis [24,25]. Higher scores indi-
cate higher levels of disorder.
Fatigue is measured with the 8-itemed “Subjective Fa-
tigue” subscale of the Checklist Individual Strength (CIS)
[26]. The outcomes per question are given in a 7-point
scale, ranging from the statement ‘totally right’ to the
statement ‘totally wrong’. The total score is counted in
points with a range of 1-7 per question and a total score
range of 8-56 points. The CIS is a sensitive instrument
with good discriminating power and reliability [26].The external criterion for distinguishing between
improved and unimproved subjects was a 7-point global
perceived effect (GPE) scale. The categories of improve-
ment included the following: completely recovered,
much improved, slightly improved, not changed, slightly
worse, much worse, and vastly worsened.
Statistical analyses
Descriptive statistics were used to describe the study
population and the number of missing values. Data sym-
metry was tested by use of visual inspection of the data
distribution plotted by histograms. Psychometric qual-
ities of the LEFS were expressed by floor- and ceiling
effects, internal consistency, test-retest reliability, min-
imally detectable change, construct validity, discriminant
validity and responsiveness.
Floor and ceiling effects
Floor and ceiling effects were determined by calculating
the number of individuals that obtained the lowest (0) or
highest (80) scores possible and were considered present
if more than 15% of the participants achieved the highest
or lowest score [27].
Internal consistency and dimensionality
Internal consistency – an indicator for the homogeneity
of a questionnaire - was assessed with Cronbach’s alpha
and 95% confidence intervals (95% CI’s). Internal
consistency is considered good when Cronbach’s alpha
lies between 0.7 and 0.9 [28]. Dimensionality was
assessed by performing principal component factor ana-
lysis with loading coefficient absolute value suppression
at 0.40 on the LEFS, KOOS-PF and HOOS-PF to deter-
mine if the individual items loaded on a single factor.
Factor extraction had three requirements: scree plot
point of inflection at the second Eigenvalue, Eigenvalue
cut-off >1.0, and ≥10% variance [29].
Reliability and minimal detectable change
Reliability concerns the degree to which the results of
measurement are consistent across repeated measure-
ments [28]. Test-retest reliability of the Dutch LEFS was
determined by means of Intraclass Correlation Coeffi-
cients (ICCs) (two-way random effects model absolute
agreement) and Bland and Altman plots [30]. The ICC
(2,1) equals variance between patients divided by vari-
ance between patients plus variance between measure-
ments plus error variance. The value of the ICC ranges
from 0 to 1, where one represents perfect reliability of
the measurement. Consequently, to quantify the reliabil-
ity of the LEFS scores we determined the standard error
of measurement (SEM=SD[√1-ICC]). The SEM is a rep-
resentation of measurement error expressed in the same
units as the original measurement. We quantified the
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dence level (MDC90 and MDC95) by multiplying the
point estimate of the SEM, the square root of 2 (to
account for the error associated with repeated measure-
ments), and the z score of 1.65 or 1.96 (resp. 90% or
95% confidence level); formula MDC90 = SEM * 1.65 *
√2 and MDC95 = SEM * 1.96 * √2 [31].
Validity
Construct validity reflects the extent to which a particu-
lar measure consistently relates to other measures with
theoretically derived hypotheses for the constructs that
are being measured [28]. To evaluate the construct val-
idity of the LEFS, we formulated a set of 16 hypotheses
(eight for knee osteoarthritis and eight for hip osteoarth-
ritis) about the expected magnitude and direction of
relationships between the LEFS and other instruments.
If 75% or more of the arbitrarily set number of 16 hy-
potheses were confirmed we defined the construct valid-
ity of the LEFS as good [32,33].
Discriminant validity was examined for the LEFS and the
physical function subscale of the HOOS and KOOS, by
contrasting its correlation with the PF subscale of the SF-
36 with its correlation with the bodily pain subscale of the
SF-36. Meng et al’s test for dependent data was used to
evaluate the differences between those correlations [34].
Responsiveness
We studied the responsiveness of the LEFS and the
WOMAC-PF extracted from the HOOS-PF and KOOS-
PF) in a combined hip and knee group, as only a very
small number of patients reported clinically important
change, thus not allowing to study the responsiveness of
the HOOS and KOOS separately. As yet, a variety of re-
sponsiveness statistics is available. However, it is not yet
known which of these statistics is better for assessing re-
sponsiveness [35] we utilized three different analyses.
First we determined the Responsiveness Ratio of Guyatt
(GRI: average change of recovered patients (GPE = 1-2)/
SD of average change of stable patients (GPE= 3-5)). If
the responsiveness ratio is larger than 1, the mean
change score in clinically improved patients exceeds the
measurement error and the instrument may be consid-
ered to be responsive, to an extent that is proportional
to the magnitude of the responsiveness ratio [36,37].
Second, we determined the Standardized Response
Mean (SRM: average score change/SD of score change).
By use of the modified Jackknife testing, we assessed dif-
ferences in SRM statistically [38]. Third, we calculated
Receiver operating characteristic curves (ROC) for the
improved subjects and for the worsened subjects using
the change scores of the questionnaires and the patients’
ratings of change [39]. The patients’ rating of change
was dichotomized to identify those subjects whoexperienced a clinically meaningful reduction of symp-
toms. Important change was defined as ‘Much Improve-
ment (GPE= 1-2)’ or ‘Much Decline (GPE = 6-7)’.
Consequently, we computed the area under the curve
(AUC). An AUC of 1.0 indicates perfect discrimination,
whereas an AUC of 0.50 indicates no performance better
than chance.
Results
Four-hundred and one individuals returned the baseline
questionnaire in the study (response rate 82%). After the
baseline questionnaire, 121 participants received a
follow-up mailing to evaluate test-retest reliability (106
responded (88%)) and 125 participants received a follow-
up mailing to evaluate the responsiveness (112
responded (90%)). Patient characteristics at baseline and
follow-up are presented in Table 1.
The majority of patients (86%) had less than three
missing values. The proportion of missing values in the
LEFS questionnaire (4%) was slightly less than the pro-
portion of missing values in the KOOS (5%) and the
HOOS (8%) questionnaires. The item ‘getting in or out
of bath’ had the highest number of missing values in
each of the questionnaires; 5% in the HOOS, 7% in the
LEFS and 10% in the KOOS.
Floor and ceiling effects
None of the 401 participants reported the lowest pos-
sible score whereas one patient (0.26%) reported the
highest functional level implying that the Dutch LEFS
has no floor or ceiling effects. In addition, the distribu-
tion of the LEFS was symmetrical.
Internal validity and factoral structure
The internal consistency for the total group of patients
(n = 401) reached a Cronbach’s alpha of 0.96 (lower limit
(LL) 95%-CI: 0.95) for the 20 items. For the hip and knee
osteoarthritis group Cronbach’s alpha reached 0.97 (LL
95%-CI: 0.96) and 0.95 (LL 95%-CI: 0.94), respectively.
Within-scale principal component factor analysis
revealed that all items included in the LEFS, KOOS-PF
and HOOS-PF loaded on a single major factor (Table 2).
Reliability and minimal detectable change
Within three weeks after the baseline questionnaire, five
individuals improved (5%) (GPE= 1-2), three worsened
(3%) (GPE= 6-7) and the majority (92%) remained stable
(GPE = 3-5). Two-way random effects ANOVA demon-
strated that the ICC of the Dutch LEFS questionnaire
for the total group (n = 106) was 0.86. For the knee
group (n = 81) and the hip group (n = 25) the ICC was
0.87 and 0.78, respectively. The standard error of meas-
urement was 4.4 points. The MDC90 and MDC95 of the
Table 1 Patient and disease characteristics at baseline from the total group and the follow-up data from the reliability
and the responsiveness sample*
N Baseline sample Reliability sample (≤3 weeks) Responsiveness sample (≥3 months)
401 106 112
Age, mean (SD) 58 (13) 61 (11) 58 (11)
Female, ♀% 231 (58%) 65 (63%) 59 (54%)
Index joint, knee 284 (71%) 81 (76%) 81 (72%)
BMI, median (IQR) 26 (24-29) 26 (24-30) 27 (24-30)
Education, higher† 77 (20%) 25 (25%) 27 (25%)
Duration complaints, >5 years† 144 (61%) 72 (63%) 59 (58%)
Co-morbidities, yes 192 (52%) 52 (50%) 63 (72%)
Baseline data Follow-up data
Hip group Knee Group Hip group Knee Group Hip group Knee Group
N 117 284 25 81 31 81
LEFS 36.0 (16.6) 39.6 (14.1) 29.8 (13.5) 36.4 (13.7) 34.3 (17.0) 37.5 (15.0)
HOOS/KOOS
Pain, mean (SD) 44.6 (21.3) 49.9 (20.0) 41.7 (21.1) 46.5 (19.7) 43.6 (23.7) 53.8 (19.3)
Symptoms, mean (SD) 41.6 (21.4) 54.6 (19.3) 40.2 (20.3) 52.5 (20.5) 39.7 (23.5) 55.8 (19.6)
Function, daily living, mean (SD) 47.5 (21.9) 56.5 (21.7) 43.8 (21.0) 54.2 (20.3) 46.5 (24.0) 57.8 (21.4)
Function, sports and recreation,
median (IQR)
25 (6-38) 10 (0-30) 13 (6-25) 5 (0-25) 19 (6-31) 10 (0-25)
Quality of life, median (IQR) 25 (13-38) 25 (13-44) 31 (19-38) 25 (13-38) 25 (13-38) 31 (19-44)
SF36
Pain, mean (SD) 35.6 (8.9) 37.3 (8.2) 35.6 (6.5) 38.6 (7.3) 37.0 (8.0) 39.9 (8.3)
Functioning, mean (SD) 31.8 (9.8) 32.8 (9.2) 29.8 (8.5) 32.5 (8.2) 31.0 (10.0) 33.4 (9.5)
HADS (total), median (IQR) 9 (5-16) 9 (4-15) N/A N/A N/A N/A
CIS, mean (SD) 34.8 (12.6) 31.0 (13.6) N/A N/A N/A N/A
* Figures are numbers and percentages in the brackets unless indicated differently. †Cut-off arbitrarily chosen. Abbreviations: BMI = Body Mass Index, IQR = Inter
Quartile Range, SD= Standard Deviation.
Table 2 Factor Analysis: Variance Explained for the LEFS,
KOOS and HOOS*
Factor Initial Eigenvalues
Total % of variance Cumulative %
LEFS
Factor 1 10.84 54.18 54.18
Factor 2 1.87 9.33 63.51
Factor 3-20 0.96 - 0.06 36.49 100.00
KOOS
Factor 1 9.76 57.42 57.42
Factor 2 1.46 8.61 66.03
Factor 3-17 0.86 - 0.05 33.97 100.00
HOOS
Factor 1 9.69 57.01 57.01
Factor 2 1.50 8.83 65.84
Factor 3 1.02 5.98 71.82
Factor 4 0.94 - 0.07 28.18 100.00
* A principal component factor analysis with loading coefficient absolute value
suppression at 0.40.
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respectively.
The Bland-Altman plot (Figure 1) shows that the mean
difference between the two applications of the LEFS was
1.87 points (95%-CI 0.22 to 3.52). The limits of agreement
(mean±1.96 SD) ranged from -11.56 to 15.30 points.
Validity
Thirteen of the 16 predefined hypotheses to determine the
construct validity were confirmed (81%) (Tables 3 and 4).
The following three hypotheses could not be confirmed.
In the hip group we found a correlation of 0.55 between
LEFS and CIS scores, which was higher than the prede-
fined cut-off of 0.5. In the knee group we found that the
duration of complaints did not influence the LEFS scores
and that education level (primary, secondary or higher
education) did influence the LEFS scores.
Meng et al’s test demonstrated that the association of
the LEFS with the SF-36 subscale pain differed signifi-
cantly with the SF-36 subscale physical functioning



























Figure 1 Bland & Altman plot.
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for pain (p< 0.01). We found no significant differences be-
tween the association with SF-36 subscale’s pain and phys-
ical functioning and the HOOS-PF (r (95%-CI) = 0.64
(0.51 - 0.74) and 0.71 (0.60 - 0.79), p =0.21) and the
KOOS-PF (0.69 (0.62 - 0.75) and 0.73 (0.67 - 0.79),
p=0.20, respectively), indicating that both questionnaires
do not discriminate between pain and physical functioning.Table 3 Predefined hypotheses and the confirmation or
rejection of the hypotheses for hip OA (n = 117) and knee
OA (n = 284)
Hip OA Knee OA
There is a moderate correlation (r> 0.6)
between LEFS scores and HOOS/KOOS-PF
subscale.
Yes Yes
The correlation between the LEFS and the
HOOS/KOOS-PF subscale is higher than
the correlation between the LEFS
and the other subscales of the
HOOS/KOOS.
Yes Yes
The correlation between LEFS and HADS
scores is low (r< 0.5).
Yes Yes
The correlation between LEFS and CIS
scores is low (r< 0.5).
No Yes
Patients with multiple painful lower
limb joints demonstrate lower LEFS scores
than patients with pain in a single joint.
Yes Yes
Patients with complaints less than 5 years
demonstrate higher LEFS scores than
patients with complaints over 5 years.
Yes No
The participants’ education level (primary,
secondary or higher education) does not
influence the LEFS scores.
Yes No
Sociodemographic characteristics, such as
sex, doing volunteer work, income,
type of health insurance, and family status,
are unrelated (r< 0.2) to the LEFS score:
Yes Yes
7/8 (88%) 6/8 (75%)
Abbreviations: CIS = Checklist Individuals Strength, HADS =Hospital Anxiety
and Depression Questionnaire, HOOS=Hip Osteoarthritis and Outcome Score,
KOOS= Knee Osteoarthritis and Outcome Score, LEFS = Lower Extremity
Functional Scale, OA= osteoarthritis, PF = physical function.Responsiveness
Seven people (7%) reported relevant improvements in func-
tion (GPE=1-2), nine people reported relevant worsening
(8%) (GPE=6-7) and the majority remained stable (85%)
(GPE=3-5). Responsiveness Ratio of the LEFS was 1.49,
close to the outcomes of WOMAC-PF (1.20) and SF36-PF
(1.22) (Table 5). Modified Jackknife testing demonstrated
no statistical differences between the SRM for the LEFS
(0.13) compared with the SRM of the WOMAC (SRM=
0.02, p= 0.45) and SF-36 (SRM=0.00, p= 0.36). ROC
curve analysis revealed that for improved patients the AUC
was 0.76 (95% CI: 0.49 - 1.00) for the LEFS, 0.71 (95% CI:
0.45 - 0.98) for the WOMAC-PF (extracted from the
HOOS-PF and KOOS-PF) and 0.68 (0.44 - 0.93) for the
SF36-PF. For worsened patients the AUC was 0.63 (95%
CI: 0.42 - 0.83) for the LEFS, 0.56 (0.34 - 0.78) for the
WOMAC-PF and 0.56 (0.35 - 0.78) for the SF36-PF.
Discussion
The primary objective of this study was to create a reli-
able and valid Dutch version of LEFS by translation and
adaptation. No difficulties were encountered in the
translation phase of the study; the structure of the ori-
ginal LEFS was not altered and all items were main-
tained. Moreover, participants reported no problems in
the administration of the questionnaire. Considering the
results of this validation study, we deemed the DutchTable 4 Correlation data for the hip OA (n =117) and
knee OA (n= 284) groups at baseline
Correlation with LEFS
Hip group Knee group
r (95%-CI) r (95%-CI)
HOOS/KOOS
Pain 0.71 (0.60 – 0.79) 0.65 (0.58 - 0.72)
Symptoms 0.56 (0.41 – 0.67) 0.42 (0.32 – 0.52)
Function, daily living 0.78 (0.69 – 0.84) 0.78 (0.73 – 0.83)
Function, sports and
recreation
0.74 (0.64 – 0.82) 0.63 (0.55 – 0.70)
Quality of life 0.72 (0.62 – 0.80) 0.60 (0.52 – 0.67)
SF36
Pain 0.51 (0.35 – 0.64) 0.66 (0.59 – 0.72)
Functioning 0.82 (0.75 – 0.88) 0.81 (0.77 – 0.85)
HADS
Anxiety −0.25† (-0.42 – -0.07) −0.10 (-0.22 – 0.02)
Depression −0.30† (-0.46 – -0.12) −0.28 (-0.38 – -0.16)
CIS −0.55† (-0.67 – -0.41) −0.47 (-0.56 – -0.37)
†Due to the inverted scales, the correct interpretation of negative associations
is that more anxiety/depression/fatigue is associated with worse function.
Abbreviations: CIS = Checklist Individuals Strength, HADS =Hospital Anxiety
and Depression Questionnaire, HOOS=Hip Osteoarthritis and Outcome Score,
IQR = Inter-quartile range, KOOS= Knee Osteoarthritis and Outcome Score,
LEFS = Lower Extremity Functional Scale, OA = osteoarthritis.










LEFS 1.42 14.41 11.25 12.50 8.38 0.13 1.49
WOMAC-PF 0.19 14.84 8.86 9.66 8.06 0.02 1.20
SF36-PF 0.00 22.73 13.68 14.44 11.86 0.00 1.22
Abbreviations: GPE =Global perceived effect, GRI =Guyatt Responder Ratio, LEFS = Lower Extremity Functional Scale, SD= Standard Deviation, SF-36-PF = Short
Form 36 - Physical Function scale, SRM= Standardized Response Mean, WOMAC=Western Ontario and McMasters University Osteoarthritis Index - Physical
Hoogeboom et al. BMC Musculoskeletal Disorders 2012, 13:117 Page 7 of 10
http://www.biomedcentral.com/1471-2474/13/117version of the LEFS to be an internally consistent, uni-
dimesional, highly reliable and valid questionnaire to de-
termine lower extremity functioning in patients with hip
or knee osteoarthritis. Finally, the LEFS revealed good
responsiveness by detecting improvement in patient
GPE; however this finding should be interpreted with
caution, given the small proportion of patient to actually
report clinically relevant functional improvement. For
our secondary objective, we were unable to demonstrate
that the HOOS-PF and KOOS-PF subscales are able to
discriminate between pain and physical function.
Construct validity of the Dutch version of the LEFS was
good as most of the pre-formulated hypotheses were met.
Three of the 16 hypotheses could however not be con-
firmed. First, in the hip group, the correlation between the
lower extremity functioning (LEFS) and fatigue (CIS) was
over 0.5 in the hip group, however similar correlations
were found for HOOS-PF (r = 0.55) and SF-36 PF
(r = 0.50). As comparative measures also demonstrate such
a relation, fatigue might have a stronger relation with
functioning than previously thought [10,15]. An important
difference with previous studies is that we investigated fa-
tigue with a fatigue-specific questionnaire in contrast to
others that used the vitality scale of the SF-36 [10,15]. Sec-
ond, participants with knee symptoms for less than five
years did not report significantly less symptoms than
patients with symptoms for over 5 years. Again this find-
ing was also found for the KOOS-PF (p=0.90) and the
SF-36 PF (p= 0.75). These findings, could however, be
biased by a phenomenon called response shift, which
could have resulted in an underreporting of functional dis-
abilities in the group with the longest duration of com-
plaints [40]. Third and final, in the knee group we found
that participants’ education level (primary, secondary or
higher education) did influence the LEFS scores. It would
be undesirable if LEFS scores were influenced by educa-
tion level, as this would indicate that the LEFS is difficult
to interpret. Further scrutiny of this finding indicates that
patients with knee symptoms who enjoyed a higher educa-
tion reported less symptoms than patients without or only
primary education (p=0.02); also when adjusted for age,
sex, BMI, co-morbidities, duration of complaints and
being employed. Yet again, this finding was also found for
the KOOS-PF (p= 0.04), but not for the SF-36 PF subscale
(p= 0.08). Our findings are in contrast to a previous study
Function scale.that addressed the relation between the LEFS scores (Ital-
ian version) and education levels. This discrepancy can
possibly explained by the different format of the Italian
version; an interview-format instead of a self-reported
questionnaire [15]. It would be of interest to further eluci-
date this relation in other studies.
Although the responsiveness of the Dutch LEFS was good
and superior to the WOMAC-PF and SF36-PF, compared
to Italian validation study by Cacchio et al. (2010) (AUC=
0.86) it was somewhat low [15]. On the other hand, the
psychometric properties of the Dutch LEFS (i.e. Cronbach’s
alpha [12,15], reproducibility [12,13,15] and validity [12,13])
were comparable to the findings of previous validation
studies. Our results regarding the responsiveness of the
LEFS, WOMAC-PF and SF36-PF, should be interpreted
with caution. Given the small number of patients reporting
clinically relevant change which may have impacted for ex-
ample the magnitude of the SRM, the point estimates
might be spurious. Future (intervention) studies should fur-
ther investigate the responsiveness of the Dutch LEFS.
The lack of discriminant validity for the WOMAC-PF
has been demonstrated in numerous occasions [6-9,41,42].
Therefore, the greater discriminant validity of the LEFS
compared to the WOMAC-PF [13,14] was one of the fore-
most reasons to translate and adapt the LEFS to the Dutch
language. In our study we compared the LEFS question-
naire to the HOOS-PF and KOOS-PF subscales. As the
physical function subscale of the HOOS and KOOS are
very similar to the WOMAC-PF, these subscales are also
at great risk for lacking discriminant validity. Our results
indicate that the LEFS, but not the KOOS-PF and the
HOOS-PF, could discriminate from pain measures, that is,
KOOS-PF and HOOS-PF did not show a statistically
higher correlation with the PF subscale than with the bod-
ily pain subscale of the SF-36, whereas the LEFS did. As
far as we know, we are the first to also demonstrate the
lack of discriminant validity in the (Dutch version of the)
HOOS and KOOS subscales, as in those particular valid-
ation studies only SF-36 subscales other than the bodily
pain subscale were examined [10,11,16].
A limitation of our study is that we recruited only
individuals with hip and knee osteoarthritis. Originally
the LEFS has been developed as a measure that could be
used for all kinds of conditions of the lower extremity
[12]. The exclusion of other condition hampers the
Hoogeboom et al. BMC Musculoskeletal Disorders 2012, 13:117 Page 8 of 10
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lower extremity. We did however evaluate the LEFS ability
to differentiate between patients with and without add-
itional lower extremity pain co-morbidities, which demon-
strated a linear association between the number of lower
extremity joint pain co-morbidities and LEFS scores. The
latter analysis showed promise that the Dutch version of
the LEFS is also able to detect functional disabilities in
patients with other symptoms than just hip and knee osteo-
arthritis. Another limitation of this study is that we did not
assess the association between the Dutch version of the
LEFS and a set of performance measures to determine the
convergent validity. Future studies should investigate this
association. A third limitation, the Cronbach’s Alpha value
surpassed the cut-off value of 0.90 indicating item redun-
dancy. However, due to the magnitude of our study sample
and relatively high number of items this figure might have
been inflated [43]. Finally, we studied the construct validity
of the LEFS by testing hypotheses according to prespecifiedOnmogelijk,
of heel veel
moeite








3. in of uit bad stappen 0
4. lopen binnenshuis 0
5. uw schoenen of sokken aantrekken 0
6. hurken 0
7. iets van de grond optillen, zoals
een tas met boodschappen
0
8. lichte taken uitvoeren in en om uw
huis
0
9. zware taken uitvoeren in en om uw
huis
0
10. in of uit een auto stappen 0
11. 250 meter lopen 0
12. anderhalve kilometer lopen 0
13. een trap op- of aflopen (ongeveer
10 treden)
0
14. één uur staan 0
15. één uur zitten 0
16. hardlopen op een vlakke ondergrond 0
17. hardlopen op een oneffen ondergrond 0
18. tijdens het rennen scherpe bochten
maken
0
19. huppen op het aangedane been 0
20. omdraaien in bed 0cut-off values; however cut-off value are often too rigid by
their dichotomous (true/false) nature. Future studies should
consider using the lower or upper bound of the 95% confi-
dence interval of an association.
Conclusions
We found that the Dutch version of the LEFS has no floor
and ceiling effects, good internal consistency, reliability,
construct validity and responsiveness. Moreover, the
Dutch LEFS demonstrated discriminant validity for pain,
as it was able to discriminate between pain and physical
functioning, whereas both the HOOS-PF and KOOS-PF
did not. Therefore, we recommend the use of the Dutch
LEFS as an outcome measure for physical functioning in
patients with hip and/or knee osteoarthritis.
Appendix A. Dutch version of LEFS
Beste meneer/mevrouw,







1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
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eden niet meer doet.
Score: _____/80 punten.
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